呼吸器合胞体ウイルス診断の世界市場（～2026年）

• 英文タイトル：Global Respiratory Syncytial Virus Diagnostics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04492 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は呼吸器合胞体ウイルス診断のグローバル市場について調査・分析したレポートです。種類別（直接蛍光抗体法、迅速抗原診断検査、分子診断、クロマトグラフィーイムノアッセイ、画像診断、ゲル微小液滴、フローサイトメトリー、その他）市場規模、用途別（病院、実験室、診療所、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別呼吸器合胞体ウイルス診断の競争状況、市場シェア ・世界の呼吸器合胞体ウイルス診断市場：種類別市場規模 2015年-2020年（直接蛍光抗体法、迅速抗原診断検査、分子診断、クロマトグラフィーイムノアッセイ、画像診断、ゲル微小液滴、フローサイトメトリー、その他） ・世界の呼吸器合胞体ウイルス診断市場：種類別市場規模予測 2021年-2026年（直接蛍光抗体法、迅速抗原診断検査、分子診断、クロマトグラフィーイムノアッセイ、画像診断、ゲル微小液滴、フローサイトメトリー、その他） ・世界の呼吸器合胞体ウイルス診断市場：用途別市場規模 2015年-2020年（病院、実験室、診療所、在宅医療） ・世界の呼吸器合胞体ウイルス診断市場：用途別市場規模予測 2021年-2026年（病院、実験室、診療所、在宅医療） ・北米の呼吸器合胞体ウイルス診断市場分析：米国、カナダ ・ヨーロッパの呼吸器合胞体ウイルス診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの呼吸器合胞体ウイルス診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の呼吸器合胞体ウイルス診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの呼吸器合胞体ウイルス診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Becton Dickinson、Abbott Laboratories、Abbott、Beckman Coulter/Danaher、Bio-Rad Laboratories、Coris BioConcept、DiaSorin SPA、Eiken Chemical、Elitech、Fujirebio、Grifols、Hoffmann La Roche、Hologic、Novartis Diagnostics、Ortho Clinical Diagnostics、Roche Diagnostics、Scienion ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others.
North America dominates the market for respiratory syncytial virus diagnosis because of the rising incidence of these infections and the increasing number of babies. In addition, the medical system continues to evolve, and more and more government initiatives, China, India, Japan and Malaysia are expected to become the fastest growing markets in the region.

Market Analysis and Insights: Global Respiratory Syncytial Virus Diagnostics Market
The global Respiratory Syncytial Virus Diagnostics market size is projected to reach US$ 599.3 million by 2026, from US$ 564.4 million in 2020, at a CAGR of 5.7%% during 2021-2026.

Global Respiratory Syncytial Virus Diagnostics Scope and Market Size
Respiratory Syncytial Virus Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Becton Dickinson
Abbott Laboratories
Abbott
Beckman Coulter/Danaher
Bio-Rad Laboratories
Coris BioConcept
DiaSorin SPA
Eiken Chemical
Elitech
Fujirebio
Grifols
Hoffmann La Roche
Hologic
Novartis Diagnostics
Ortho Clinical Diagnostics
Roche Diagnostics
Scienion

Market segment by Type, the product can be split into
Direct Fluorescent Antibody Method
Rapid Antigen Diagnostic Tests
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Other
Market segment by Application, split into
Hospitals
Laboratory
Clinics
Homecare

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Respiratory Syncytial Virus Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Direct Fluorescent Antibody Method
1.4.3 Rapid Antigen Diagnostic Tests
1.4.4 Molecular Diagnostics
1.4.5 Chromatographic Immunoassay
1.4.6 Diagnostic Imaging
1.4.7 Gel Microdroplets
1.4.8 Flow Cytometry
1.4.9 Other
1.5 Market by Application
1.5.1 Global Respiratory Syncytial Virus Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Laboratory
1.5.4 Clinics
1.5.5 Homecare
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Diagnostics Market Perspective (2015-2026)
2.2 Global Respiratory Syncytial Virus Diagnostics Growth Trends by Regions
2.2.1 Respiratory Syncytial Virus Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Respiratory Syncytial Virus Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Respiratory Syncytial Virus Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Respiratory Syncytial Virus Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Market Size
3.1.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Respiratory Syncytial Virus Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio
3.2.1 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Diagnostics Revenue in 2019
3.3 Respiratory Syncytial Virus Diagnostics Key Players Head office and Area Served
3.4 Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
3.5 Date of Enter into Respiratory Syncytial Virus Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)
5.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
6.2 Respiratory Syncytial Virus Diagnostics Key Players in North America (2019-2020)
6.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
6.4 North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
7.2 Respiratory Syncytial Virus Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
7.4 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)

8 China
8.1 China Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
8.2 Respiratory Syncytial Virus Diagnostics Key Players in China (2019-2020)
8.3 China Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
8.4 China Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
9.2 Respiratory Syncytial Virus Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
9.4 Japan Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
10.2 Respiratory Syncytial Virus Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)

11 India
11.1 India Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
11.2 Respiratory Syncytial Virus Diagnostics Key Players in India (2019-2020)
11.3 India Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
11.4 India Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Respiratory Syncytial Virus Diagnostics Market Size (2015-2020)
12.2 Respiratory Syncytial Virus Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Becton Dickinson
13.1.1 Becton Dickinson Company Details
13.1.2 Becton Dickinson Business Overview
13.1.3 Becton Dickinson Respiratory Syncytial Virus Diagnostics Introduction
13.1.4 Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020))
13.1.5 Becton Dickinson Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Introduction
13.2.4 Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Respiratory Syncytial Virus Diagnostics Introduction
13.3.4 Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Beckman Coulter/Danaher
13.4.1 Beckman Coulter/Danaher Company Details
13.4.2 Beckman Coulter/Danaher Business Overview
13.4.3 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Introduction
13.4.4 Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.4.5 Beckman Coulter/Danaher Recent Development
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview
13.5.3 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Introduction
13.5.4 Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development
13.6 Coris BioConcept
13.6.1 Coris BioConcept Company Details
13.6.2 Coris BioConcept Business Overview
13.6.3 Coris BioConcept Respiratory Syncytial Virus Diagnostics Introduction
13.6.4 Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.6.5 Coris BioConcept Recent Development
13.7 DiaSorin SPA
13.7.1 DiaSorin SPA Company Details
13.7.2 DiaSorin SPA Business Overview
13.7.3 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Introduction
13.7.4 DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.7.5 DiaSorin SPA Recent Development
13.8 Eiken Chemical
13.8.1 Eiken Chemical Company Details
13.8.2 Eiken Chemical Business Overview
13.8.3 Eiken Chemical Respiratory Syncytial Virus Diagnostics Introduction
13.8.4 Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.8.5 Eiken Chemical Recent Development
13.9 Elitech
13.9.1 Elitech Company Details
13.9.2 Elitech Business Overview
13.9.3 Elitech Respiratory Syncytial Virus Diagnostics Introduction
13.9.4 Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.9.5 Elitech Recent Development
13.10 Fujirebio
13.10.1 Fujirebio Company Details
13.10.2 Fujirebio Business Overview
13.10.3 Fujirebio Respiratory Syncytial Virus Diagnostics Introduction
13.10.4 Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
13.10.5 Fujirebio Recent Development
13.11 Grifols
10.11.1 Grifols Company Details
10.11.2 Grifols Business Overview
10.11.3 Grifols Respiratory Syncytial Virus Diagnostics Introduction
10.11.4 Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.11.5 Grifols Recent Development
13.12 Hoffmann La Roche
10.12.1 Hoffmann La Roche Company Details
10.12.2 Hoffmann La Roche Business Overview
10.12.3 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Introduction
10.12.4 Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.12.5 Hoffmann La Roche Recent Development
13.13 Hologic
10.13.1 Hologic Company Details
10.13.2 Hologic Business Overview
10.13.3 Hologic Respiratory Syncytial Virus Diagnostics Introduction
10.13.4 Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.13.5 Hologic Recent Development
13.14 Novartis Diagnostics
10.14.1 Novartis Diagnostics Company Details
10.14.2 Novartis Diagnostics Business Overview
10.14.3 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.14.4 Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.14.5 Novartis Diagnostics Recent Development
13.15 Ortho Clinical Diagnostics
10.15.1 Ortho Clinical Diagnostics Company Details
10.15.2 Ortho Clinical Diagnostics Business Overview
10.15.3 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.15.4 Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.15.5 Ortho Clinical Diagnostics Recent Development
13.16 Roche Diagnostics
10.16.1 Roche Diagnostics Company Details
10.16.2 Roche Diagnostics Business Overview
10.16.3 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
10.16.4 Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.16.5 Roche Diagnostics Recent Development
13.17 Scienion
10.17.1 Scienion Company Details
10.17.2 Scienion Business Overview
10.17.3 Scienion Respiratory Syncytial Virus Diagnostics Introduction
10.17.4 Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020)
10.17.5 Scienion Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Respiratory Syncytial Virus Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Respiratory Syncytial Virus Diagnostics Revenue
Table 3. Ranking of Global Top Respiratory Syncytial Virus Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Direct Fluorescent Antibody Method
Table 6. Key Players of Rapid Antigen Diagnostic Tests
Table 7. Key Players of Molecular Diagnostics
Table 8. Key Players of Chromatographic Immunoassay
Table 9. Key Players of Diagnostic Imaging
Table 10. Key Players of Gel Microdroplets
Table 11. Key Players of Flow Cytometry
Table 12. Key Players of Other
Table 13. Global Respiratory Syncytial Virus Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Respiratory Syncytial Virus Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Respiratory Syncytial Virus Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Respiratory Syncytial Virus Diagnostics Market Share by Regions (2015-2020)
Table 17. Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Respiratory Syncytial Virus Diagnostics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Respiratory Syncytial Virus Diagnostics Market Growth Strategy
Table 23. Main Points Interviewed from Key Respiratory Syncytial Virus Diagnostics Players
Table 24. Global Respiratory Syncytial Virus Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Respiratory Syncytial Virus Diagnostics Market Share by Players (2015-2020)
Table 26. Global Top Respiratory Syncytial Virus Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus Diagnostics as of 2019)
Table 27. Global Respiratory Syncytial Virus Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
Table 30. Date of Enter into Respiratory Syncytial Virus Diagnostics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Respiratory Syncytial Virus Diagnostics Market Size Share by Type (2015-2020)
Table 34. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type (2021-2026)
Table 35. Global Respiratory Syncytial Virus Diagnostics Market Size Share by Application (2015-2020)
Table 36. Global Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Respiratory Syncytial Virus Diagnostics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Respiratory Syncytial Virus Diagnostics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Respiratory Syncytial Virus Diagnostics Market Share (2019-2020)
Table 40. North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Respiratory Syncytial Virus Diagnostics Market Share by Type (2015-2020)
Table 42. North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Respiratory Syncytial Virus Diagnostics Market Share by Application (2015-2020)
Table 44. Europe Key Players Respiratory Syncytial Virus Diagnostics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Respiratory Syncytial Virus Diagnostics Market Share (2019-2020)
Table 46. Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Respiratory Syncytial Virus Diagnostics Market Share by Type (2015-2020)
Table 48. Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Respiratory Syncytial Virus Diagnostics Market Share by Application (2015-2020)
Table 50. China Key Players Respiratory Syncytial Virus Diagnostics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Respiratory Syncytial Virus Diagnostics Market Share (2019-2020)
Table 52. China Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. China Respiratory Syncytial Virus Diagnostics Market Share by Type (2015-2020)
Table 54. China Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. China Respiratory Syncytial Virus Diagnostics Market Share by Application (2015-2020)
Table 56. Japan Key Players Respiratory Syncytial Virus Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Respiratory Syncytial Virus Diagnostics Market Share (2019-2020)
Table 58. Japan Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Respiratory Syncytial Virus Diagnostics Market Share by Type (2015-2020)
Table 60. Japan Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Respiratory Syncytial Virus Diagnostics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Respiratory Syncytial Virus Diagnostics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Respiratory Syncytial Virus Diagnostics Market Share (2019-2020)
Table 64. Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Respiratory Syncytial Virus Diagnostics Market Share by Type (2015-2020)
Table 66. Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Respiratory Syncytial Virus Diagnostics Market Share by Application (2015-2020)
Table 68. India Key Players Respiratory Syncytial Virus Diagnostics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Respiratory Syncytial Virus Diagnostics Market Share (2019-2020)
Table 70. India Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. India Respiratory Syncytial Virus Diagnostics Market Share by Type (2015-2020)
Table 72. India Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. India Respiratory Syncytial Virus Diagnostics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Respiratory Syncytial Virus Diagnostics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Respiratory Syncytial Virus Diagnostics Market Share (2019-2020)
Table 76. Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Respiratory Syncytial Virus Diagnostics Market Share by Type (2015-2020)
Table 78. Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Respiratory Syncytial Virus Diagnostics Market Share by Application (2015-2020)
Table 80. Becton Dickinson Company Details
Table 81. Becton Dickinson Business Overview
Table 82. Becton Dickinson Product
Table 83. Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 84. Becton Dickinson Recent Development
Table 85. Abbott Laboratories Company Details
Table 86. Abbott Laboratories Business Overview
Table 87. Abbott Laboratories Product
Table 88. Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 89. Abbott Laboratories Recent Development
Table 90. Abbott Company Details
Table 91. Abbott Business Overview
Table 92. Abbott Product
Table 93. Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 94. Abbott Recent Development
Table 95. Beckman Coulter/Danaher Company Details
Table 96. Beckman Coulter/Danaher Business Overview
Table 97. Beckman Coulter/Danaher Product
Table 98. Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 99. Beckman Coulter/Danaher Recent Development
Table 100. Bio-Rad Laboratories Company Details
Table 101. Bio-Rad Laboratories Business Overview
Table 102. Bio-Rad Laboratories Product
Table 103. Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 104. Bio-Rad Laboratories Recent Development
Table 105. Coris BioConcept Company Details
Table 106. Coris BioConcept Business Overview
Table 107. Coris BioConcept Product
Table 108. Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 109. Coris BioConcept Recent Development
Table 110. DiaSorin SPA Company Details
Table 111. DiaSorin SPA Business Overview
Table 112. DiaSorin SPA Product
Table 113. DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 114. DiaSorin SPA Recent Development
Table 115. Eiken Chemical Business Overview
Table 116. Eiken Chemical Product
Table 117. Eiken Chemical Company Details
Table 118. Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 119. Eiken Chemical Recent Development
Table 120. Elitech Company Details
Table 121. Elitech Business Overview
Table 122. Elitech Product
Table 123. Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 124. Elitech Recent Development
Table 125. Fujirebio Company Details
Table 126. Fujirebio Business Overview
Table 127. Fujirebio Product
Table 128. Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 129. Fujirebio Recent Development
Table 130. Grifols Company Details
Table 131. Grifols Business Overview
Table 132. Grifols Product
Table 133. Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 134. Grifols Recent Development
Table 135. Hoffmann La Roche Company Details
Table 136. Hoffmann La Roche Business Overview
Table 137. Hoffmann La Roche Product
Table 138. Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 139. Hoffmann La Roche Recent Development
Table 140. Hologic Company Details
Table 141. Hologic Business Overview
Table 142. Hologic Product
Table 143. Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 144. Hologic Recent Development
Table 145. Novartis Diagnostics Company Details
Table 146. Novartis Diagnostics Business Overview
Table 147. Novartis Diagnostics Product
Table 148. Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 149. Novartis Diagnostics Recent Development
Table 150. Ortho Clinical Diagnostics Company Details
Table 151. Ortho Clinical Diagnostics Business Overview
Table 152. Ortho Clinical Diagnostics Product
Table 153. Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 154. Ortho Clinical Diagnostics Recent Development
Table 155. Roche Diagnostics Company Details
Table 156. Roche Diagnostics Business Overview
Table 157. Roche Diagnostics Product
Table 158. Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 159. Roche Diagnostics Recent Development
Table 160. Scienion Company Details
Table 161. Scienion Business Overview
Table 162. Scienion Product
Table 163. Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2015-2020) (Million US$)
Table 164. Scienion Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Syncytial Virus Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Direct Fluorescent Antibody Method Features
Figure 3. Rapid Antigen Diagnostic Tests Features
Figure 4. Molecular Diagnostics Features
Figure 5. Chromatographic Immunoassay Features
Figure 6. Diagnostic Imaging Features
Figure 7. Gel Microdroplets Features
Figure 8. Flow Cytometry Features
Figure 9. Other Features
Figure 10. Global Respiratory Syncytial Virus Diagnostics Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Laboratory Case Studies
Figure 13. Clinics Case Studies
Figure 14. Homecare Case Studies
Figure 15. Respiratory Syncytial Virus Diagnostics Report Years Considered
Figure 16. Global Respiratory Syncytial Virus Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Respiratory Syncytial Virus Diagnostics Market Share by Regions: 2020 VS 2026
Figure 18. Global Respiratory Syncytial Virus Diagnostics Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Respiratory Syncytial Virus Diagnostics Market Share by Players in 2019
Figure 21. Global Top Respiratory Syncytial Virus Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus Diagnostics as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus Diagnostics Revenue in 2019
Figure 23. North America Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed

---